Clinical trial
A Phase I Evaluation of the Safety of the TriVascular Stent-Graft System in the Treatment of Abdominal Aortic Aneurysms
NCT00646048 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Evaluation of the Safety of the TriVascular Stent-Graft System in the Treatment of Abdominal Aortic Aneurysms
- Lead sponsor
- Boston Scientific Corporation
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- February 28, 2003
- Completion date
- March 31, 2010
- Enrollment
- 43 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
abdominal aortic aneurysm